drugset / Trial / NCT00046878

Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

NCT00046878

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. O(6)-benzylguanine may increase the effectiveness of carmustine by making tumor cells more sensitive to the drug. PURPOSE: Phase II trial to study the effectiveness of combining carmustine with O(6)-benzylguanine in treating patients who have newly diagnosed supratentorial glioblastoma multiforme.

Timeline

Start
Primary completion
Completion
2002-08

Drugs

EvaluationDrugModalityDoseRoute
Subject O6-benzylguanine Small molecule Intravenous
Subject carmustine Small molecule Intravenous